CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Diabetes Mellitus D003920 90 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Chondrosarcoma D002813 9 associated lipids
Chancroid D002602 4 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Carcinoma 256, Walker D002279 22 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Body Weight D001835 333 associated lipids
Birth Weight D001724 23 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Asthma D001249 52 associated lipids
Arteriosclerosis D001161 86 associated lipids
Anemia D000740 21 associated lipids
Alzheimer Disease D000544 76 associated lipids
Adenocarcinoma D000230 166 associated lipids
Congenital Abnormalities D000013 11 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Aikawa M et al. Interactions between macrophagelike cells and Leishmania braziliensis in vitro. 1982 Am. J. Pathol. pmid:7091302
Elbim C et al. Heterogeneity in Lewis-X and sialyl-Lewis-X antigen expression on monocytes in whole blood: relation to stimulus-induced oxidative burst. 1998 Am. J. Pathol. pmid:9546369
Russo MA et al. Ultrastruct pathology of phalloidin-intoxicated hepatocytes in the presence and absence of extracellular calcium. 1982 Am. J. Pathol. pmid:6890315
Fantone JC et al. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production. 1984 Am. J. Pathol. pmid:6324595
Okayasu T et al. Cytochalasin delays but does not prevent cell death from anoxia. 1984 Am. J. Pathol. pmid:6541879
O'Flaherty JT et al. Neutrophil aggregation and degranulation. Effect of arachidonic acid. 1979 Am. J. Pathol. pmid:453323
Matsumura N et al. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). 1999 Am. J. Pathol. pmid:10362789
O'Flaherty JT et al. Substances which aggregate neutrophils. Mechanism of action. 1978 Am. J. Pathol. pmid:356621
Hsu LS and Becker EL Volume changes induced in rabbit polymorphonuclear leukocytes by chemotactic factor and cytochalasin B. 1975 Am. J. Pathol. pmid:1180327
Ohta M et al. Changes in the organization and antigenic determinants of intermediate filaments of rat hepatocytes after infusion of cytochalasin B in vivo. 1988 Am. J. Pathol. pmid:2462355
Ogawa H et al. Comparative study of eosinophil and neutrophil chemotaxis and enzyme release. 1981 Am. J. Pathol. pmid:7294162
Holland JA et al. Atherogenic levels of low-density lipoprotein increase endocytotic activity in cultured human endothelial cells. 1992 Am. J. Pathol. pmid:1546741
Mease AD et al. Irreversible neutrophil aggregation. A mechanism of decreased newborn neutrophil chemotactic response. 1981 Am. J. Pathol. pmid:7258298
White JG and Rao GH Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. 1998 Am. J. Pathol. pmid:9466587
Mukherjee C and Lynn WS Role of ions and extracellular protein in leukocyte motility and membrane ruffling. 1978 Am. J. Pathol. pmid:717536
Schollmeyer JV et al. An actin-binding protein in human platelets. Interactions with alpha-actinin on gelatin of actin and the influence of cytochalasin B. 1978 Am. J. Pathol. pmid:717537
Webster RO et al. Enhancement of human polymorphonuclear leukocyte adherence to plastic and endothelium by phorbol myristate acetate. Comparison with human C5a. 1986 Am. J. Pathol. pmid:3789092
Ginsberg M et al. Mechanisms of platelet response to monosodium urate crystals. 1979 Am. J. Pathol. pmid:426039
Escolar G et al. Organization of the actin cytoskeleton of resting and activated platelets in suspension. 1986 Am. J. Pathol. pmid:2870643
Wysolmerski RB and Lagunoff D Inhibition of endothelial cell retraction by ATP depletion. 1988 Am. J. Pathol. pmid:3394800
Liu S et al. Dynamic modulation of cytoskeleton during in vitro maturation in human oocytes. 2010 Am. J. Obstet. Gynecol. pmid:20579967
Kniss DA et al. Expression of functional insulin-like growth factor-I receptors by human amnion cells. 1993 Am. J. Obstet. Gynecol. pmid:8372873
Sato N et al. Hyposmolarity stimulates myeloperoxidase exocytosis from human polymorphonuclear leukocytes. 1990 Am. J. Med. Sci. pmid:2159710
Mooradian AD and Morin AM Brain uptake of glucose in diabetes mellitus: the role of glucose transporters. 1991 Am. J. Med. Sci. pmid:2000888
Jacobs DB Fat cells: model system to investigate molecular mechanism(s) of sulfonylurea-potentiated glucose transport. 1985 Am. J. Med. pmid:3931463
Wann JG et al. Enhanced expression of glucose transporter 1 on erythrocyte membrane in hemodialysis patients: the possible role in erythrocyte ascorbate recycling. 2006 Am. J. Kidney Dis. pmid:16731301
Standley PR and Rose KA Insulin and insulin-like growth factor-1 modulation of glucose transport in arterial smooth muscle cells: implication of GLUT-4 in the vasculature. 1994 Am. J. Hypertens. pmid:8031552
Berkow RL and Dodson RW Functional analysis of the marginating pool of human polymorphonuclear leukocytes. 1987 Am. J. Hematol. pmid:3026170
Stagno PA and Low FN Effects of cytochalasin B on the fine structure of organized endodermal cells of the early chick embryo. 1978 Am. J. Anat. pmid:626150
Nicosia SV and Tojo R Morphogenetic reaggregation and luteinization of mouse preantral follicle cells. 1979 Am. J. Anat. pmid:532792
Rhoten WB Emiocytosis of B granules from saurian pancreatic islets perifused in vitro. 1973 Am. J. Anat. pmid:4585905
Bondareff W and Tuttle RL Cortical cytoplasm and configurational changes of RGC-6 cells exposed to cytochalasin B. 1975 Am. J. Anat. pmid:1211367
Holtzer H et al. Effects of cytochalasin-B and colcimide on cells in muscle cultures. 1974 Am. J. Anat. pmid:4413125
Holtzer H et al. Effects of Cytochalasin-B and colcimide on cells in muscle cultures. 1974 Am. J. Anat. pmid:4440631
Webster W and Langman J The effect of cytochalasin B on the neuroepithelial cells of the mouse embryo. 1978 Am. J. Anat. pmid:567005
Harik SI et al. The hexose transporter of human erythrocytes in aging and Alzheimer dementia. 1989 Alzheimer Dis Assoc Disord pmid:2597423
Zeck-Kapp G et al. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations. 1995 Allergy pmid:7741187
Takafuji S et al. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a. 1996 Allergy pmid:8874660
Hückel C et al. [The role of the cytoskeleton in lymphocyte stimulation]. 1985 Allerg Immunol (Leipz) pmid:3161315
Lundqvist C et al. Agonist-stimulated and basal phosphatidylethanol formation in neutrophils from alcoholics. 1994 Alcohol. Clin. Exp. Res. pmid:7943658
Wei M et al. [Analysis of gene expression patterns of leukemia K562 cells after cytochalasin B treatment]. 2003 Ai Zheng pmid:12654177
Naef A The relationship between the transient cAMP peak and various leucocyte responses. 1983 Agents Actions Suppl. pmid:6301236
Albinus M and Mayer B The effects of antimitotic and microfilament disrupting agents on functions of isolated guinea-pig parietal cells. 1985 Agents Actions pmid:4040314
Baggiolini M et al. Effect of benzydamine on exocytosis and respiratory burst in human neutrophils and mononuclear phagocytes. 1985 Agents Actions pmid:2996321
Fantozzi R et al. FMLP-activated neutrophils evoke histamine release from mast cells. 1986 Agents Actions pmid:2425573
Tasaka K et al. Distribution of actin filaments in rat mast cells and its role in histamine release. 1986 Agents Actions pmid:2425590
Mannaioni PF et al. Studies on the 14C-histamine release induced by noradrenaline in mouse neoplastic mast cells. 1975 Agents Actions pmid:56875
Moroni F et al. Studies on the 14C-histamine release induced by histamine in mouse neoplastic mast cells. 1975 Agents Actions pmid:56876
Marone G et al. Histamine release from human basophils by pepstatin A. 1985 Agents Actions pmid:2413738
Schnitzler S et al. Histamine release from rat mast cells induced by protamine sulfate and polyethylene imine. 1981 Agents Actions pmid:6166172